EUVIMEDEUVIMED entdecken
Crossref

KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathway

Yang He, Pengzhan He, Shimin Lu, Weiguo Dong

Digestive and Liver Disease · 2023

DOI: 10.1016/j.dld.2023.02.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive and Liver Disease, 2023. Verfasst von Yang He und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; Central Laboratory of Renmin Hospital, Wuhan, Hube…. Hauptthemen laut MEDLINE: Stomach Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: KIFC3 is a member of the kinesin family which has shown great promise in cancer therapy recently. In this study, we sought to elucidate the role of KIFC3 in the development of GC and its possible mechanisms. METHODS: Two databases and a tissue microarray were used to explore the expression of KIFC3 and its correlation with patients' clinicopathological characteristics. Cell proliferation was examined by cell counting kit-8 assay and colony formation assay. Wound healing assay and transwell assay were performed to examine cell metastasis ability. EMT and Notch signaling related proteins were detected by western blot. Additionally, a xenograft tumor model was established to investigate the function of KIFC3 in vivo. RESULTS: The expression of KIFC3 was upregulated in GC, and was associated with higher T stage and poor prognosis in GC patients. The proliferation and metastasis ability of GC cells were promoted by KIFC3 overexpression while inhibited by KIFC3 knockdown in vitro and in vivo. Furthermore, KIFC3 might activate the Notch1 pathway to facilitate the progression of GC, and DAPT, an inhibitor of Notch signaling, could reverse this effect. CONCLUSION: Together, our data revealed that KIFC3 could enhance the progression and metastasis of GC by activating the Notch1 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsAnimalsHumansCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalGene Expression Regulation, NeoplasticReceptors, NotchSignal TransductionReceptor, Notch1Kinesins

Stichwörter der Autor:innen

EMTGastric cancerKIFC3NotchOncogene

Substanzen

Receptors, NotchNOTCH1 protein, humanReceptor, Notch1KIFC1 protein, humanKinesins

Autor:innen und Institutionen

  • Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; Central Laboratory of Renmin Hospital, Wuhan, Hubei Province, China.
  • Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China; Central Laboratory of Renmin Hospital, Wuhan, Hubei Province, China. Electronic address: dongweiguog@whu.edu.cn.

Zitieren

APA

He, Y., He, P., Lu, S., & Dong, W. (2023). KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathway. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2023.02.014

Vancouver

He Y, He P, Lu S, Dong W. KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathway. Digestive and Liver Disease. 2023. doi:10.1016/j.dld.2023.02.014

BibTeX
@article{He2023,
  author = {He, Yang and He, Pengzhan and Lu, Shimin and Dong, Weiguo},
  title = {KIFC3 Regulates the progression and metastasis of gastric cancer via Notch1 pathway},
  journal = {Digestive and Liver Disease},
  year = {2023},
  doi = {10.1016/j.dld.2023.02.014}
}
Kostenlos starten →